Abstract
Fossil fuel combustion processes that generate greenhouse gases (GHG) also emit and or cause the creation of other harmful air pollutants. Thus, while policies designed to avert the course of climate change would eventually result in direct human health benefits from lessened global temperature changes and associated impacts, they would also bring much more immediate ancillary human health co-benefits from the associated reduced ground-level air pollution in the short term. Several measures aimed at reducing GHG emissions, notably the reduced use of fossil fuels such as coal, can also improve local air quality, most notably particulate matter (PM) and ozone (O3) air pollution. Further, whereas the benefits from climate change mitigation would materialize far in the future, these co-benefits, or ancillary benefits, would provide much more immediate “return on investment” in climate change mitigation. Thus, as detailed below, the near-term human health co-benefits of climate mitigation (e.g., fossil fuel emission reductions) may provide the most economically compelling justification for immediate action towards climate change mitigation. Here we discuss the health impacts of PM and ozone, two key air pollutants that have substantial impacts on human health and that are likely to be reduced by policies aimed at controlling GHG emissions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Swart R, Amann M, Raes F, Tuinstra W. A good climate for clean air: linkages between climate change and air pollution: an editorial essay. Clim Change. 2004;66:263–9.
Thurston GD. Air pollution, human health, climate change and you. Thorax. 2007;62:748–9.
Walsh MP. Ancillary benefits for climate change mitigation and air pollution control in the world’s motor vehicle fleets. Annu Rev Public Health. 2008;29:1–9.
Haines A, Smith KR, Anderson D, et al. Policies for accelerating access to clean energy, improving health, advancing development, and mitigating climate change. Lancet. 2007;370:1264–81.
Smith KR, Haigler E. Co-benefits of climate mitigation and health protection in energy systems: scoping methods. Annu Rev Public Health. 2008;29:11–25.
Smith KR, Jerrett M, Anderson HR, et al. Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants. Lancet. 2009;374(9707):2091–103.
USEPA. The benefits and costs of the Clean Air Act 1990 to 1999. Washington, DC: USEPA; 2010. EPA-410-R-99-001.
Thurston GD, Ito K, Kinney PL, Lippmann M. A multi-year study of air pollution and respiratory hospital admissions in three New York State metropolitan areas: results for 1988 and 1989 summers. J Expo Anal Environ Epidemiol. 1992;2(4):429–50.
Kinney PL, Ito K, Thurston GD. A sensitivity analysis of mortality/PM10 associations in Los Angeles. Inhal Toxicol. 1995;7:59–69.
Thurston GD. A critical review of PM10-mortality time-series studies. J Expo Anal Environ Epidemiol. 1996;6:3–22.
Schwartz J. Health effects of air pollution from traffic: ozone and particulate matter. In: Fletcher T, McMichael AJ, editors. Health at the crossroads: transport policy and urban health. New York, NY: Wiley; 1997.
Dominici F, Peng RD, Bell ML, et al. Fine particulate air pollution and hospital admissions for cardiovascular and respiratory diseases. J Am Med Assoc. 2006;295(10):1127–34.
Samoli E, Peng R, Ramsay T, et al. Acute effects of ambient particulate matter on mortality in Europe and North America: results from the APHENA study. Environ Health Perspect. 2008;116(11):1480–6.
USEPA. Regulatory impact analysis for the final clean air interstate rule. Washington, DC: USEPA; 2005. EPA-452/R-05-002.
Bell ML, Dominici F, Samet JM. Time-series of particulate matter. Annu Rev Public Health. 2004;25:247–80.
Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103(23):2810–5.
Dominici F, McDermott A, Daniels M, Zeger SL, Samet JM. Revised analyses of the National Morbidity, Mortality, and Air Pollution Study: mortality among residents of 90 cities. J Toxicol Environ Health A. 2005;68:1071–92.
Ozkaynak H, Thurston GD. Associations between 1980 U.S. mortality rates and alternative measures of airborne particle concentration. Risk Anal. 1987;7:449–60.
Dockery DW, Pope III CA, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329(24):1753–9.
Pope III CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality and long-term exposure to fine particulate air pollution. JAMA. 2002;287(9):1132–41.
Eftim SE, Samet JM, Janes H, McDermott A, Dominici F. Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a Medicare cohort. Epidemiology. 2008;19(2):209–16.
Chen H, Goldberg MS, Villeneuve PJ. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev Environ Health. 2008;23(4):243–97.
Bell ML, Dominici F, Ebisu K, Zeger SL, Samet JM. Spatial and temporal variation in PM2.5 chemical composition in the United States for health effects studies. Environ Health Perspect. 2007;115(7):989–95.
Thurston GD, Ito K, Mar T, et al. Workgroup report: workshop on source apportionment of particulate matter health effects—intercomparison of results and implications. Environ Health Perspect. 2005;113(12):1768–74.
Bell ML, Ebisu K, Peng RD, Samet JM, Dominici F. Hospital admissions and chemical composition of fine particle air pollution. Am J Respir Crit Care Med. 2009;179(12):1115–20. Epub 2009 Mar 19.
Lall R, Ito K, Thurston GD. Distributed lag analyses of daily hospital admissions and source-apportioned fine particle air pollution. Environ Health Perspect. 2010;119(4):455–60.
Ito K, Mathes R, Ross Z, Nádas A, Thurston G, Matte T. Fine particulate matter constituents associated with cardiovascular hospitalizations and mortality in New York City. Environ Health Perspect. 2011;119(4):467–73.
Zhou J, Ito K, Lall R, Lippmann M, Thurston GD. Time-series analysis of mortality effects of fine particulate matter components in Detroit and Seattle. Environ Health Perspect. 2011;119(4):461–6.
Spira-Cohen A, Chen LC, Kendall M, Lall R, Thurston GD. Personal exposures to traffic-related air pollution and acute respiratory health among Bronx school children with asthma. Environ Health Perspect. 2011;119(4):559–65.
Ostro B, Lipsett M, Reynolds P, et al. Long-term exposure to constituents of fine particulate air pollution and mortality: results from the California teachers study. Environ Health Perspect. 2010;118(3):363–9.
U.S. Environmental Protection Agency. Air quality criteria for ozone and related photochemical oxidants. Research Triangle Park, NC: Office of Research and Development; 2006. Report nos. EPA 600/R-05/004aF.
Gauderman WJ, McConnell R, Gilliland F, London S, Thomas D, Avol E, Vora H, Berhane K, Rappaport EB, Lurmann F, Margolis HG, Peters J. Association between air pollution and lung function growth in southern California children. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1383–90.
Gauderman WJ, Gilliland GF, Vora H, Avol E, Stram D, McConnell R, Thomas D, Lurmann F, Margolis HG, Rappaport EB, Berhane K, Peters JM. Association between air pollution and lung function growth in southern California children: results from a second cohort. Am J Respir Crit Care Med. 2002;166(1):76–84.
Rojas-Martinez R, Perez-Padilla R, Olaiz-Fernandez G, Mendoza-Alvarado L, Moreno-Macias H, Fortoul T, McDonnell W, Loomis D, Romieu I. Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med. 2007;176:377–84.
Mudway IS, Kelly FJ. An investigation of inhaled ozone dose and the magnitude of airway inflammation in healthy adults. Am J Respir Crit Care Med. 2004;169:1089–95.
Levy JI, Carrothers TJ, Tuomisto JT, Hammitt JK, Evans JS. Assessing the public health benefits of reduced ozone concentrations. Environ Health Perspect. 2001;109:1215–26.
Stieb DM, Judek S, Burnett RT. Meta-analysis of time-series studies of air pollution and mortality: effects of gases and particles and the influence of cause of death, age, and season. J Air Waste Manage Assoc. 2002;52:470–84.
Thurston GD, Ito K. Epidemiological studies of acute ozone exposures and mortality. J Expo Anal Environ Epidemiol. 2001;11:286–94.
World Health Organization. Meta-analysis of time-series studies and panel studies of particulate matter (PM) and ozone (O3): report of a WHO task group. Copenhagen, Denmark: WHO Regional Office for Europe. 2004. Document no. EUR/04/5042688. http://www.euro.who.int/document/E82792.pdf. Accessed 18 Nov 2004.
Bell ML, Dominici F, Samet JM. A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology. 2005;16:436–45.
Ito K, De Leon SF, Lippmann M. Associations between ozone and daily mortality, analysis and meta-analysis. Epidemiology. 2005;16:446–57.
Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987–2000. J Am Med Assoc. 2004;292:2372–8.
Gryparis A, Forsberg B, Katsouyanni K, Analitis A, Touloumi G, Schwartz J, Samoli E, Medina S, Anderson HR, Niciu EM, Wichmann HE, Kriz B, Kosnik M, Skorkovsky J, Vonk JM, Dörtbudak Z. Acute effects of ozone on mortality from the “air pollution and health: a European approach” project. Am J Respir Crit Care Med. 2004;170:1080–7.
Schwartz J. How sensitive is the association between ozone and daily deaths to control for temperature? Am J Respir Crit Care Med. 2005;171:627–31.
Bell ML, Dominici F. Effect modification by community characteristics on the short-term effects of ozone exposure and mortality in 98 U.S. communities. Am J Epidemiol. 2008;167:986–97.
O’Neill MS, Loomis D, Borja-Aburto VH. Ozone, area social conditions, and mortality in Mexico City. Environ Res. 2004;94:234–42.
Jerrett M, Burnett RT, Pope III CA, Ito K, Thurston G, Krewski D, Shi Y, Calle J, Thun M. The contribution of long-term ozone exposure to mortality. N Engl J Med. 2009;360:108595.
USEPA. The benefits and costs of the Clean Air Act 1970 to 1990. Washington, DC: USEPA; 1997.
Ebi K, Mills DM, Smith JB, Grambsch A. Climate change and human health impacts in the United States: an update on the results of the U.S. national assessment. Environ Health Perspect. 2006;114:1318–24.
Bell ML, Davis DL, Cifuentes LA, Krupnick AJ, Morgenstern RD, Thurston GD. Ancillary human health benefits of improved air quality resulting from climate change mitigation. Environ Health. 2008;7:41.
Burtraw D, Toman M. The benefits of reduced air pollutants in the U.S. from greenhouse gas mitigation policies. Washington, DC: Resources for the Future; 1997. Discussion Paper 98-01-REV.
McCarthy JJ, Canziani OF, Leary NA, Dokken DJ, White KS, editors. Climate change 2001: impacts, adaptation & vulnerability. Contribution of working group II to the third assessment report of the intergovernmental panel on climate change. Cambridge: Cambridge University Press; 2001.
Cifuentes L, Borja-Aburto VH, Gouveia N, Thurston GD, Davis DL. Assessing the health benefits of urban air pollution reductions associated with climate change mitigation (2000–2020): Santiago, São Paulo, Mexico City, and New York City. Environ Health Perspect. 2000;2001(109):S419–25.
Last J, Trouton K, Pengelly D. Taking our breath away: the health effects of air pollution and climate change. Vancouver, Canada: David Suzuki Foundation; 1988.
Wang X, Smith KR. Near-term health benefits of greenhouse gas reductions: a proposed assessment method and application in two energy sectors of China. Geneva: World Health Organization; 1999. WHO/SDE/PHE/99.1.
Cao J, Ho MS, Jorgenson DW. “Co-benefits” of greenhouse gas mitigation policies in China. Washington, DC: Resources for the Future; 2008.
Vennemo H, Aunan K, Jinghua F, et al. Domestic environmental benefits of China’s energy-related CDM potential. Clim Change. 2006;75:215–39.
Alcamo J, Mayerhofer P, Gaurdans R, et al. An integrated assessment of regional air pollution and climate change in Europe: findings of the IAR-CLIM project. Environ Sci Pol. 2002;5:257–72.
van Harmelen T, Bakker J, de Vries B, van Vuuren D, den Elzen J, Mayerhofer P. Long-term reductions in costs of controlling regional air pollution in Europe due to climate policy. Environ Sci Pol. 2002;5:349–65.
Working Group on Public Health and Fossil Fuel Combustion. Short-term improvements in public health from global-climate policies on fossil-fuel combustion: an interim report. Lancet. 1997;350:1341–9.
Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of major health impairments: a comparative analysis of cancer, motor vehicle injuries, coronary heart disease, and stroke. Lexington, MA: Lexington Books; 1981.
Miller W, Robinson LA, Lawrence RS, editors. Institute of Medicine (IOM) Committee to evaluate measures of health benefits for environmental, health, and safety regulation. Valuing stratus consulting: air quality valuation model documentation, for Health Canada. Boulder, CO: Stratus Consulting; 1999.
Committee on Estimating the Health-Risk-Reduction Benefits of Proposed Air Pollution Regulations, National Research Council. Estimating the public health benefits of proposed air pollution regulations. Washington, DC: National Academies Press; 2002.
Voorhees SA. Benefits analysis of particulate matter control programs – a case study of Tokyo. 2005;8(4):311–29.
Krewski D, Burnett R, Jerrett M, Pope C, Rainham D, Calle E, Thurston G, Thun M. Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. J Toxicol Environ Health A. 2005;68:1093–109.
Filleul L, Rondeau V, Vandentorren S, Le Moual N, Cantagrel A, Annesi-Maesano I, et al. Twenty five year mortality and air pollution: results from the French PAARC survey. Occup Environ Med. 2005;62:453–60.
Bickel P, Friedrich RE. ExternE, externalities of energy, methodology 2005 update. Luxemburg: European Commission; 2005.
Stern N. The economics of climate change: the stern review. New York, NY: Cambridge University Press; 2007.
Further Reading
Ammann CM, Washington WM, Meehl GA, Buja L, Teng H. Climate engineering through artificial enhancement of natural forcings: magnitudes and implied consequences. J Geophys Res. 2010;115(22), D22109.
Anderson GB, Bell ML. Does one size fit all? The suitability of standard ozone exposure metric conversion ratios and implications for epidemiology. J Expo Sci Environ Epidemiol. 2010;20(1):2–11.
Ban-Weiss GA, Caldeira K. Geoengineering as an optimization problem. Environ Res Lett. 2010;5(3), 034009.
Bell ML, Peng RD, Dominci F. The exposure-response curve for ozone and risk of mortality and the adequacy of current ozone regulations. Environ Health Perspect. 2006;114:532–6.
Bell ML, Kim JY, Dominici F. Potential confounding of particulate matter on the short-term association between ozone and mortality in multisite time-series studies. Environ Health Perspect. 2007;115:1591–5.
Chen LH, Knutsen SF, Shavlik D, et al. The association between fatal coronary heart disease and ambient particulate air pollution: are females at greater risk? Environ Health Perspect. 2005;113:1723–9.
Cifuentes L, Borja-Aburto VH, Gouveia N, Thurston GD, Davis DL. Climate change. Hidden health benefits of greenhouse gas mitigation. Science. 2001;293(5533):1257–9.
Goldstein B, Kobos PH, Brady PV. Unintended consequences of atmospheric injection of sulphate aerosol. SAND2010-7571. Albuquerque, NM: Sandia National Laboratories; 2010.
Intergovernmental Panel on Climate Change (IPCC). Climate change 2007: the physical science basis. Summary for policymakers. Contribution of working group I to the fourth assessment report of the intergovernmental panel on climate change. Geneva: IPCC Secretariat; 2007.
Kious WJ, Tilling RI. This dynamic earth: the story of plate tectonics. Washington, D.C.: USGS, USGPO; 1996.
Krupnick A, Davis D, Thurston GD. The ancillary health benefits and costs of GHG mitigation: scope, scale, and credibility. In: Workshop on assessing the ancillary benefits and costs of greenhouse gas mitigation strategies. Washington, DC: Organization for Economic Cooperation and Development (OECD), Intergovernmental Panel on Climate Change (IPCC); 2000.
Miller W, Robinson LA, Lawrence RS, editors. Valuing health for regulatory cost-effectiveness analysis. Washington, DC: National Academies Press; 2006.
Moore JC, Jevrejeva S, Grinsted A. Efficacy of geoengineering to limit 21st century sea-level rise. Proc Natl Acad Sci USA. 2010;107(36):15699–703. Epub 2010 Aug 23.
National Academy of Science (NAS). Radiative forcing of climate change: expanding the concept and addressing uncertainties. Washington, DC: National Research Council, Committee on Radiative Forcing Effects on Climate, Climate Research Committee; 2005.
Ostro B, Feng WY, Broadwin R, Green S, Lipsett M. The effects of components of fine particulate air pollution on mortality in California: results from CALFINE. Environ Health Perspect. 2007;115(1):13–9.
Rasch PJ, Tilmes S, Turco RP, et al. An overview of geoengineering of climate using stratospheric sulphate aerosols. Philos Trans A Math Phys Eng Sci. 2008;366:4007–37.
Tuck AF, Donaldson DJ, Hitchman MH, et al. On geoengineering with sulphate aerosols in the tropical upper troposphere and lower stratosphere. Clim Change. 2008;90:315–31.
Voorhees AS, Sakai R, Araki S, Sato H, Otsu A. Benefits analysis of nitrogen dioxide control programmes: a case-study of Chiyoda-ku, Tokyo. J Environ Plann Manag. 2001;44:149–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thurston, G.D., Bell, M.L. (2014). The Human Health Co-benefits of Air Quality Improvements Associated with Climate Change Mitigation. In: Pinkerton, K., Rom, W. (eds) Global Climate Change and Public Health. Respiratory Medicine, vol 7. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-8417-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8417-2_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-8416-5
Online ISBN: 978-1-4614-8417-2
eBook Packages: MedicineMedicine (R0)